30431592|t|Rapid-onset hyponatremia and delirium following duloxetine treatment for postherpetic neuralgia: Case report and literature review.
30431592|a|RATIONALE: Hyponatremia following duloxetine treatment has been reported in patients with major depressive disorder, fibromyalgia, diabetic neuropathy, or sciatic pain. The manifestations of duloxetine-induced hyponatremia are varying in different individuals. The overall prognosis for this type of hyponatremia is favorable if properly managed. PATIENT CONCERNS AND DIAGNOSES: Herein, we reported rapid-onset hyponatremia and delirium in an older patient after 2 doses of duloxetine, which was used to control his postherpetic neuralgia. Laboratory examinations revealed a rapid decline in serum sodium level and indicated the possibility of syndrome of inappropriate antidiuretic hormone (SIADH). INTERVENTIONS: Discontinuation of duloxetine, restriction of water intake, and intravenous supplement of normal saline were adopted to manage the hyponatremia. OUTCOMES: Serum concentration of sodium gradually normalized following aforementioned strategies. LESSONS: Special attention to the electrolyte abnormality is recommended in old patients undergoing duloxetine treatment.
30431592	12	24	hyponatremia	Disease	MESH:D007010
30431592	29	37	delirium	Disease	MESH:D003693
30431592	48	58	duloxetine	Chemical	MESH:D000068736
30431592	73	95	postherpetic neuralgia	Disease	MESH:D051474
30431592	143	155	Hyponatremia	Disease	MESH:D007010
30431592	166	176	duloxetine	Chemical	MESH:D000068736
30431592	208	216	patients	Species	9606
30431592	228	247	depressive disorder	Disease	MESH:D003866
30431592	249	261	fibromyalgia	Disease	MESH:D005356
30431592	263	282	diabetic neuropathy	Disease	MESH:D003929
30431592	287	299	sciatic pain	Disease	MESH:D010146
30431592	323	333	duloxetine	Chemical	MESH:D000068736
30431592	342	354	hyponatremia	Disease	MESH:D007010
30431592	432	444	hyponatremia	Disease	MESH:D007010
30431592	479	486	PATIENT	Species	9606
30431592	543	555	hyponatremia	Disease	MESH:D007010
30431592	560	568	delirium	Disease	MESH:D003693
30431592	581	588	patient	Species	9606
30431592	606	616	duloxetine	Chemical	MESH:D000068736
30431592	648	670	postherpetic neuralgia	Disease	MESH:D051474
30431592	730	736	sodium	Chemical	MESH:D012964
30431592	776	822	syndrome of inappropriate antidiuretic hormone	Disease	MESH:D007177
30431592	824	829	SIADH	Disease	MESH:D007177
30431592	866	876	duloxetine	Chemical	MESH:D000068736
30431592	978	990	hyponatremia	Disease	MESH:D007010
30431592	1025	1031	sodium	Chemical	MESH:D012964
30431592	1124	1147	electrolyte abnormality	Disease	MESH:D014883
30431592	1170	1178	patients	Species	9606
30431592	1190	1200	duloxetine	Chemical	MESH:D000068736
30431592	Negative_Correlation	MESH:D000068736	MESH:D003866
30431592	Positive_Correlation	MESH:D000068736	MESH:D007177
30431592	Positive_Correlation	MESH:D000068736	MESH:D007010
30431592	Negative_Correlation	MESH:D000068736	MESH:D051474
30431592	Positive_Correlation	MESH:D000068736	MESH:D003693
30431592	Association	MESH:D000068736	MESH:D014883
30431592	Negative_Correlation	MESH:D000068736	MESH:D003929
30431592	Negative_Correlation	MESH:D000068736	MESH:D010146

